In August 2023, a team of researchers including Dr. Eduard Porta, group leader at the Josep Carreras Institute, published a thorough analysis of the effects of cancer driver alterations found across different cancer types, ...
15 hours ago
0
0
In many cases of malignant melanoma, the effect of targeted treatment is lost over time. A research team from UZH and USZ has now discovered that a factor secreted by tumor cells is responsible for the resistance. These findings ...
Jun 27, 2024
0
19
When low doses of cancer drugs are administered continuously near malignant brain tumors using so-called iontronic technology, cancer cell growth drastically decreases. Researchers at Linköping University, Sweden, and the ...
Jun 19, 2024
0
1
Prof. Liu Zhibo's team from Peking University (PKU)'s College of Chemistry and Molecular Engineering, along with collaborators, recently published a paper titled "Covalent targeted radioligands potentiate radionuclide therapy" ...
Jun 4, 2024
0
0
In a new study, Yale researchers describe how a novel chemical compound attacks drug-resistant brain tumors without harming healthy surrounding tissue.
Jun 3, 2024
0
28
Cancer remains one of the most formidable public health challenges, causing significant mortality globally. In 2022 alone, there were approximately 19.3 million new cancer diagnoses and 10 million cancer-related deaths worldwide. ...
May 31, 2024
0
0
Cancer is a leading cause of death globally. One of the primary reasons why cancer is such a deadly disease is the ability of cancer cells to become drug-resistant.
May 15, 2024
0
0
By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately predict which patients with ...
Apr 29, 2024
0
55
St. Jude Children's Research Hospital scientists reversed an aggressive cancer, reverting malignant cells towards a more normal state. Rhabdoid tumors are an aggressive cancer which is missing a key tumor suppressor protein. ...
Mar 27, 2024
0
41
Jonathan Chen, MD, Ph.D., an investigator in the Department of Pathology at Massachusetts General Hospital, and Nir Hacohen, Ph.D., director of the Center of Cancer Immunology at Massachusetts General Hospital, are co-authors ...
Mar 19, 2024
0
0
